2013-01-10
| Signal | Price | Bias | Subject | Owned |
|---|---|---|---|---|
| HOLD | $33.850 | UNKNOWN | US EQUITIES | No |
Had a spinoff of their pharmaceutical side and this company now just represents the diagnostic and nutritional business. If you own, wait and see how things settle out for them.
Gordon Reid
President and CEO,
GoodReid Investment Counsel